ライフサイエンスコーパス: erythroleukemic

1 Erythroleukemic and megakaryocytic leukemia cell lines (

2 [TfR]), we developed a series of human K562 erythroleukemic cell clones retrovirally transduced with

3 n applied successfully to analysis of murine erythroleukemic cell cultures and this, when coupled wit

4 l to study how Notch regulates cell fate and erythroleukemic cell differentiation.

5 The TF-1 human erythroleukemic cell line exhibits opposing physiologica

6 In addition, the human erythroleukemic cell line K562 responded chemotactically

7 f this gene in epithelial cell lines and the erythroleukemic cell line K562.

8 in locus control region element in the human erythroleukemic cell line K562.

9 O7e cells, a growth factor-dependent CD34(+) erythroleukemic cell line, and in cord blood-derived hum

10 pressed in the reticulocytes and in the K562 erythroleukemic cell line, but not in a lymphocytic cell

11 We identified a human erythroleukemic cell line, K562, that expresses caveolin

12 in mRNA levels in single K562 cells, a human erythroleukemic cell line, with and without 30 microM he

13 of which all three genes are expressed in an erythroleukemic cell line.

14 age of the abundant mRNAs from a single K562 erythroleukemic cell or a single dorsal root ganglion ne

15 We treated both K562 erythroleukemic cells and human erythroid progenitor cel

16 eased expression of the gamma-globin gene in erythroleukemic cells as well as in primary erythroblast

17 ucleosomal chromatin derived from K562 human erythroleukemic cells by micrococcal nuclease digestion.

18 In human erythroleukemic cells deficient for ATRX, macroH2A accum

19 athways stopped the proliferation of primary erythroleukemic cells from Friend SFFV-infected mice, wi

20 Erythroleukemic cells in particular have been shown to p

21 Elevation of the level of HLTF in K562 erythroleukemic cells increases beta-promoter activity i

22 cate that the lineage plasticity observed in erythroleukemic cells reflects an intrinsic property of

23 We have utilized murine erythroleukemic cells that express a temperature-sensiti

24 n-globin gene in the adult stage and in K562 erythroleukemic cells to analyze the inactive state of t

25 of 4T1 breast adenocarcinoma cells and K562 erythroleukemic cells with IFN-gamma triggers the cellul

26 nt occurs early in differentiation of murine erythroleukemic cells, this suggests that ribosomal cont

27 hemin-induced differentiation of K562 human erythroleukemic cells.

28 ative effects of TNF-alpha may be limited to erythroleukemic cells.

29 to induce megakaryocytic differentiation in erythroleukemic cells.

30 differentiation, equivalent to that seen in erythroleukemic cells.

31 Gase, a marker of retinoid activity in human erythroleukemic cells.

32 sults in marked growth inhibition of miR-92a erythroleukemic cells.

33 sed during erythroid differentiation in K562 erythroleukemic cells.

34 econd stage is characterized by emergence of erythroleukemic clones (MEL cells) which typically bear

35 a 3-dependent adhesive properties of a human erythroleukemic (HEL) cell line.

36 ally characterized from cDNA clones of human erythroleukemic (HEL) cell mRNA, a cell line exhibiting

37 both the GM12878 (lymphoblastoid) and K562 (erythroleukemic) human hematopoietic cell lines.

38 e nitric oxide synthase (NOS-2) in the human erythroleukemic K562 cell line results in constitutive p

39 In the human erythroleukemic K562 cell line, only one DNA region has

40 ferent portions of Duffy protein as a tag in erythroleukemic K562 cells.

41 uced megakaryocytic differentiation of human erythroleukemic K562 cells.

42 of one such multiprotein complex from human erythroleukemic K562 cells.

43 sfer in both non-erythroid NIH 3T3 and mouse erythroleukemic (MEL) cells.

44 of a methylated rho-gene construct in mouse erythroleukemic (MEL)-rho cells.

45 f activated Erg was validated by reproducing erythroleukemic pathology in mice transplanted with feta

46 oson-driven disease and strong selection for erythroleukemic pathology with transformation of bipoten

47 ruitment on EPO-induced hemoglobinization in erythroleukemic SKT6 cells have been investigated.

48 In erythroleukemic SKT6 cells, this action also may enforce

49 reduced AP1 DNA-binding activity in primary erythroleukemic splenocytes from Friend SFFV-infected mi

50 n agonistic DR3 monoclonal antibody in human erythroleukemic TF-1 cells, which express DR3 endogenous

51 v-ErbA participates in erythroleukemic transformation of cells induced by the a

52 nd its overexpression has been implicated in erythroleukemic transformation.

53 involved in lysis of K562 cells because the erythroleukemic tumor target cells expressed no class II